Catalog · Metabolic

Tirzepatide

Name: Tirzepatide Research Peptide
Brand: Ethos Bio
Price: 44.99 USD
Availability: InStock

CAS 2023788-19-2MW 4,813.45 g/mol≥99.0% Purity

A dual GIP and GLP-1 receptor agonist studied for incretin-pathway signaling and metabolic regulation.

Quantity per vial

Vials

$44.99

Free cold-chain shipping over $200
Signed COA included with every vial
Batch-pinned ordering for protocol continuity

Research Use Only. Sold for research and identification purposes only. Not intended for human dosing, injection, or ingestion.

Mass-Spec Verified

HPLC + LC-MS per batch at Janoshik.

99% Purity Threshold

Below-spec lots are destroyed, not sold.

Cold-Chain 2–8°C

Continuous transit temperature logging.

U.S. cGMP Compounded

Domestic manufacturing, lot traceability.

Mechanism of action

Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In research models it is studied for the combined activation of both incretin pathways and downstream effects on insulin secretion, glucose homeostasis, and energy metabolism.

Its dual-receptor mechanism is the principal distinction from single GLP-1 agonists, making it a key reference compound in comparative incretin and metabolic-pathway research.

Full research overview, applications & FAQ →

Specifications

Compound name	Tirzepatide (LY3298176)
CAS number	2023788-19-2
Sequence / Form	Synthetic 39-aa dual-incretin agonist
Molecular weight	4,813.45 g/mol
Classification	Metabolic research compound
Purity (HPLC)	≥ 99.0%
Identity verification	LC-MS (Janoshik Analytical)
Appearance	White lyophilized powder
Storage	Lyophilized: 2–8°C, sealed. Long-term: −20°C.
Vial sizes	5 mg · 10 mg · 15 mg · 30 mg
Synthesis method	Solid-phase peptide synthesis (SPPS)

Per-lot certificate of analysis

Every shipment of Tirzepatide includes a signed Certificate of Analysis specific to the lot you receive, documenting HPLC purity, LC-MS identity confirmation, water content, and the cold-chain temperature log. Testing is performed by our independent partner, Janoshik Analytical.

View Certificate of Analysis →

Research Use Only — required disclosure

Tirzepatide, like all Ethos Bio products, is sold strictly for in-vitro and laboratory research use only. It is not a drug, food, cosmetic, or supplement; not intended for human or veterinary consumption; and not intended for the diagnosis, treatment, cure, mitigation, or prevention of any disease.

Sale is restricted to qualified researchers and institutions, aged 21+. By placing an order you certify the compound will be used solely for laboratory research consistent with 21 CFR § 201.128.